Gabapentinoids and sleep apnea syndrome: a safety signal from the WHO pharmacovigilance database

被引：0
|
作者：
Revol, B. [1 ]
Jullian-Desayes, I. [2 ]
Cracowski, J. L. [3 ]
Tamisier, R. [2 ]
Mallaret, M. [1 ]
Joyeux-Faure, M. [2 ]
Pepin, J. L. [2 ]
机构：
[1] Grenoble Alpes Univ Hosp, Pharmacovigilance Dept, Grenoble, France
[2] Grenoble Alpes Univ, HP2 Lab, INSERM, U1042, Grenoble, France
[3] Grenoble Alpes Univ Hosp, Dept Clin Pharmacol, Grenoble, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CO-006
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [1] Gabapentinoids and sleep apnea syndrome: a safety signal from the WHO pharmacovigilance database
    Revol, Bruno
    Jullian-Desayes, Ingrid
    Cracowski, Jean-Luc
    Tamisier, Renaud
    Mallaret, Michel
    Joyeux-Faure, Marie
    Pepin, Jean-Louis
    SLEEP, 2019, 42 (02)
  • [2] Gabapentinoids and Sleep Apnea Syndrome: A Safety Signal from the Who Pharmacovigilance Database
    Pepin, J.
    Revol, B.
    Jullian-Desayes, I.
    Cracowski, J.
    Tamisier, R.
    Mallaret, M.
    Joyeux-Faure, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [3] Valproic acid and sleep apnea: A disproportionality signal from the WHO pharmacovigilance database
    Revol, B.
    Jullian-Desayes, I.
    Guichard, K.
    Micoulaud-Franchi, J. A.
    Tamisier, R.
    Philip, P.
    Joyeux-Faure, M.
    Pepin, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 99 - 99
  • [4] Valproic acid and sleep apnoea: A disproportionality signal from the WHO pharmacovigilance database
    Revol, Bruno
    Jullian-Desayes, Ingrid
    Guichard, Kelly
    Micoulaud-Franchi, Jean-Arthur
    Tamisier, Renaud
    Philip, Pierre
    Joyeux-Faure, Marie
    Pepin, Jean-Louis
    RESPIROLOGY, 2020, 25 (03) : 336 - 338
  • [5] Ticagrelor and central sleep apnea: analysis of VigiBase, the WHO pharmacovigilance database
    Revol, Bruno
    Jullian-Desayes, Ingrid
    Tamisier, Renaud
    Puel, Vincent
    Mallaret, Michel
    Joyeux-Faure, Marie
    Pepin, Jean-Louis
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [6] Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance database
    Revol, Bruno
    Jullian-Desayes, Ingrid
    Bailly, Sebastien
    Mallaret, Michel
    Tamisier, Renaud
    Agier, Marie-Sara
    Lador, Frederic
    Joyeux-Faure, Marie
    Pepin, Jean-Louis
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (01)
  • [7] Baclofen and sleep apnoea syndrome: analysis of VigiBase® the WHO pharmacovigilance database
    Revol, B.
    Jullian-Desayes, I.
    Bailly, S.
    Mallaret, M.
    Tamisier, R.
    Agier, M. S.
    Lador, F.
    Joyeux-Faure, M.
    Pepin, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 42 - 42
  • [8] Kounis syndrome: A retrospective analysis of individual case safety reports from the international WHO database in pharmacovigilance
    Orion, Klaus
    Mack, Jochen
    Kullak-Ublick, Gerd A.
    Weiler, Stefan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (05) : 240 - 248
  • [9] Safety of pitolisant: a study in the WHO international pharmacovigilance database
    Montastruc, Jean-Louis
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (04) : 569 - 570
  • [10] Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
    Allouchery, Marion
    Tomowiak, Cecile
    Lombard, Thomas
    Perault-Pochat, Marie-Christine
    Salvo, Francesco
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345